Publication | Closed Access

Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: Therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats

InflammationAnti-inflammatoryMedicineChitosan CapsulesImmunologyGastroenterologyTherapeutic EffectsPharmacotherapyColon-specific DeliveryUlcerative ColitisPharmacologyDrug Discovery